Labcorp Holdings Inc
LH: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$937.00 | Jfvtzx | Vgnqxvxvr |
LabCorp Refocuses on Diagnostics With Spinoff of Drug Development Business
Business Strategy and Outlook
As a leading independent diagnostic laboratory, LabCorp participates in a highly attractive duopoly that offers favorable prospects as healthcare moves toward reformed payment models, the easing of Medicare headwinds and potentially positive M&A opportunities.